Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_assertion type Assertion NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_head.
- NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_assertion description "[We identified 418 patients with newly diagnosed GBM at University of California Los Angeles Kaiser Permanente Los Angeles, nearly all of whom received chemoradiation, and determined MGMT expression by IHC, and MGMT promoter methylation by methylation-specific PCR (MSP) and bisulfite sequencing (BiSEQ) of 24 neighboring CpG sites.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_provenance.
- NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_assertion evidence source_evidence_literature NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_provenance.
- NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_assertion SIO_000772 23328811 NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_provenance.
- NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_assertion wasDerivedFrom befree-20140225 NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_provenance.
- NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_assertion wasGeneratedBy ECO_0000203 NP793745.RAdLrZRqc4ZJg2mvO_Z38dEZE9mv9vFEqZTZoyRrAWkMA130_provenance.